Advertise on podcast: Joint Action

On this special World Arthritis Day episode of Joint Action, we are bringing together some of the most moving moments from our patient stories series, where real people share what it is like to live with osteoarthritis, and more importantly, what they did about it. Whether you are newly diagnosed, have been living with osteoarthritis for years, or are supporting someone who is, we hope today's episode reminds you that there is always something you can do. RELATED EPISODES S02E21 - Empowering patients to take control of their osteoarthritis with Dr Dawn RichardsS02E06 - Meagan's osteoarthritis journeyS04E16 - Julie's journey with osteoarthritis CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials: https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Do supplements really help with osteoarthritis, or are we wasting our money? On this week's episode of Joint Action, Associate Professor Joanna Harnett and Dr Jocelyn Bowden join Professor David Hunter to cut through the noise on complementary medicines, exploring what the evidence actually shows and how to make informed decisions about supplement use for osteoarthritis. A/Prof Joanna Harnett is an Associate Professor of Complementary Medicines at the University of Sydney's School of Pharmacy. Her research focuses on the quality use of complementary medicines and clinical studies in gastrointestinal health and the microbiome, with over 100 peer-reviewed publications and more than $1.15 million in research funding. She is Chair of the Therapeutic Goods Administration's Advisory Committee on Complementary Medicines and a Board Member of the International Society for Complementary, Traditional and Integrative Medicine Research. Dr Jocelyn Bowden is a Senior Research Fellow with the Osteoarthritis Clinical Research Group at the Kolling Institute, University of Sydney. Her research focuses on improving healthcare through evidence-based practice, including the role of complementary medicines in osteoarthritis care. She has secured over $6.5 million in research funding, published more than 60 peer-reviewed articles, and co-leads the OARSI Joint Effort Initiative for the Implementation of Osteoarthritis Management Programs. CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials: https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

What does it really mean to live with hand osteoarthritis, and how do you stay active and engaged in life when your hands are constantly painful? On this week's episode of Joint Action, Giovanna Lever joins Professor David Hunter to share her personal journey living with hand osteoarthritis, diagnosed at 45 after years of struggling with pain, and what it has meant for her work, travel, and family life. Giovanna Lever is the Founder and Managing Director of Sparrowly Group, a Sydney-based consultancy working in economic development, community development, workforce planning, and tourism strategy across Australia and the Asia-Pacific. She is an advocate for accessible and inclusive tourism and co-founder of AccessA, a platform focused on accessibility and inclusion for businesses and tourism operators. Diagnosed with arthritis in her hands in 2025, she continues to champion an active and healthy lifestyle despite a busy schedule involving work, travel, and family life. RESOURCESJournal article Efficacy of a Combination of Conservative Therapies vs an Education Comparator on Clinical Outcomes in Thumb Base OsteoarthritisA Randomized Clinical Trial Links COMBO study supplemental informationFunctional equipmentDaily living aidsAssistive devices for arthritis of the handsAssistive products Related Episodes Hormones, menopause, and joint pain with Dr Ginni MansbergHand osteoarthritis with Margreet Kloppenburg CONNECT WITH USNaia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials: https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Is platelet-rich-plasma (PRP) a game changer for osteoarthritis, or is the evidence still catching up with the hype? On this week's episode of Joint Action, Dr Hamish Osborne joins Professor David Hunter to cut through the noise on PRP exploring what the research currently shows, where the gaps in evidence lie, and how patients and clinicians can navigate the decision together. Dr Hamish Osborne is a Fellow of the Australasian College of Sport and Exercise Physicians. He works part time in private practice and part time as a senior lecturer at the University of Otago, in Dunedin, New Zealand. His main role is teaching the Post Graduate Diploma in Sport and Exercise Medicine to general practitioners and physiotherapists. He has a varied interest in research and is completing his PhD in cardiac screening in New Zealand elite basketballers. CONNECT WITH USNaia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials: https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Do your knees crack, pop, or creak when you move? On this week's episode of Joint Action, Associate Professor Danilo De Oliveira Silva joins Professor David Hunter to explain what those sounds actually mean, whether they are something to worry about, and what the research tells us about the relationship between noisy knees and osteoarthritis. A/Prof Danilo De Oliveira Silva is an Associate Professor and NHMRC Emerging Leadership Fellow at La Trobe University, Melbourne. His research focuses on the biomechanics, psychological, and pain characteristics of people with musculoskeletal conditions across the lifespan, with more than 130 peer-reviewed publications to his name. He is Editor-in-Chief of the Journal of Sport Rehabilitation, Development Director of the TREK initiative, and co-creator of a digital hub with seven online toolkits to support health professionals and patients with chronic pain. RESOURCESJournal articlesNoisy knees - knee crepitus prevalence and association with structural pathology: a systematic review and meta-­ analysisDoes it sound like a problem? Knee crepitus prevalence and self-reported frequency in runners with and without knee surgery and its association with knee osteoarthritis beliefs WebsiteTREK Education - Noisy knees (crepitus) CONNECT WITH USNaia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials: https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Should you lose weight or have your knee replaced? On this week's episode of Joint Action, Professor Marius Henriksen joins Professor David Hunter to discuss the INKA randomised controlled trial, which set out to test whether an intensive dietary weight loss program could deliver results comparable to knee arthroplasty for people with knee osteoarthritis who are eligible for surgery. Professor Marius Henriksen is a clinical professor of physiotherapy at the Faculty of Health and Medical Sciences, Copenhagen University, and head of musculoskeletal research at the Parker Institute at Copenhagen University Hospital in Denmark. His primary research focus is clinical research in osteoarthritis, with an emphasis on non-pharmacological management including exercise and weight loss. RESOURCES Journal Article: Intensive diet or knee arthroplasty for severe knee osteoarthritis: The inka randomised trial CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials: https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Have you ever wondered whether your painful, stiff joints are just something you have to put up with, or whether there is actually something that can be done? On this week's episode of Joint Action, Vicky puts your listener questions to Professor David Hunter, covering hand osteoarthritis and what treatments are available, common concerns people have when living with osteoarthritis day to day, and how to know when the time is right to consider joint replacement surgery. Dr Vicky Duong is a physiotherapist and research fellow at the Kolling Institute, University of Sydney, where her research focuses on osteoarthritis, digital health, and self-management interventions. She is co-host and producer of the Joint Action podcast, and is dedicated to sharing evidence-based knowledge with consumers to empower them to take control of their health. Professor David Hunter is a rheumatologist and the world's leading researcher in osteoarthritis, based at the Kolling Institute, University of Sydney. He is the host of the Joint Action podcast and has dedicated his career to improving the lives of people living with osteoarthritis through research, education, and advocacy. CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials: https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Could the shoes you wear every day be making your knee osteoarthritis better or worse? On this week's episode of Joint Action, Kade Paterson joins Professor David Hunter to explain why footwear matters for knee osteoarthritis and how to choose the best shoe for your joints. Associate Professor Kade Paterson is a Principal Research Fellow in the Centre for Health Exercise and Sports Medicine in the Department of Physiotherapy at the University of Melbourne and a leader in the field of walking and running biomechanics. His research focuses on lower limb biomechanics and injury, with expertise in how foot-based interventions and footwear influence musculoskeletal conditions such as osteoarthritis. Kade is also a certified sports podiatrist and has published extensively, contributing to over 90 peer‑reviewed papers and presenting internationally. He is an editorial board member for two international journals, is Co-Chair and inaugural steering committee member for the International Foot and Ankle Osteoarthritis Consortium, and President of Sports and Exercise Podiatry Australia. RESOURCES Journal articles The Effect of Flat Flexible Versus Stable Supportive Shoes on Knee Osteoarthritis Symptoms: A Randomized TrialQ&A: Choosing shoes for osteoarthritis pain CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials: https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

What happens to global science when funding is cut, borders close, and collaboration is threatened? In this special episode of Joint Action, Professor David Hunter reflects on the proposed changes to research funding and collaboration threaten global science and why speaking up, supporting one another, and protecting open, rigorous research matters now more than ever. PROVIDE FEEDBACK Office of Management and Budget (Open until July 13th, 2026) - Federal Register :: Regulation for Federal Financial Assistance CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

When we say a treatment works for knee osteoarthritis, it is worth asking: works for whom? On this week's episode of Joint Action, Professor Christian Barton unpacks the blind spots in osteoarthritis research, exploring who has and hasn't been included in the evidence base for first-line care, and what that means for the patients we treat every day. Prof Christian Barton is a physiotherapist and implementation scientist at La Trobe University, where he leads key projects including GLA:D Australia and TREK. With additional training in communications and implementation science, his research focuses on bridging the gap between evidence and practice in osteoarthritis, knee, and running injury care. He also consults privately at Complete Physio Richmond. RESOURCES Journal articles Blind spots in reporting and representation in knee osteoarthritis research: A systematic review of the sociodemographic and clinical characteristics of 22,443 participants in randomised controlled trials of first-line careWho is waiting to see the surgeon? sociodemographic, clinical characteristics and previous osteoarthritis care of people with knee osteoarthritis referred to public hospitals in Victoria, AustraliaBarriers and Facilitators for the Implementation of an Osteoarthritis Management Programs in a Low-Income Setting: An Exploratory Study of Malawian Physical Therapists CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

This week on Joint Action, Vicky turns the tables and puts the questions to Professor David Hunter. Three listeners submitted questions spanning gut health, total knee replacement, and the frustrating gap between what the research says and what patients are actually being told in clinic. It's a wide-ranging, honest conversation that's relevant whether you're living with osteoarthritis, working in healthcare, or simply want to understand the science better. RELATED EPISODES Season 6, Episode 26: Episode Your osteoarthritis questions answered by David (Part 2)Season 6, Episode 25: Episode Your osteoarthritis questions answered by David (Part 1)Season 5, Episode 26: Your osteoarthritis questions answered by DavidSeason 2, Episode 8: A chat to David and listener questions CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

The number of surgical procedures for musculoskeletal diseases such as osteoarthritis has increased exponentially over the past years, some of which are unnecessary and leave patients no better off than they were before. Knee replacement surgery can be a wonderful and cost-effective treatment for end-stage osteoarthritis but only when less invasive treatments have failed. There are many factors driving the alarming rates of increased surgery ranging from system-level factors such as inadequate reimbursement for physiotherapy treatment to personal-level factors such as individual beliefs and education of patients and their health care providers. Frequently referrals are made to surgeons as primary care doctors feel there is nothing more they can do. If you are referred it is important to be prepared for what that consultation will involve and to consider whether you truly want/ need surgery. On this episode of Joint Action, we are joined by Dr Howard Luks to discuss this topic. Dr. Howard Luks is a Board-Certified Orthopaedic Surgeon and Sports Medicine specialist. Howard graduated from New York Medical College and completed his Orthopaedic Surgery residency in 1996 and a fellowship in Sports Medicine at the Hospital for Joint Diseases in NYC in 1997. His focus is on injuries that involve the shoulder, knee, and elbow. He is the Chief of Sports Medicine and Arthroscopy at New York Medical College and Advanced Physician Services. CONNECT WITH HOWARD Website: https://www.howardluksmd.com/Podcast: https://www.howardluksmd.com/podcast/the-paul-and-howard-show/ CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Can identifying the right patients and the right endpoints transform how we test new osteoarthritis treatments? On this week's episode of Joint Action, we unpack what the FNIH Biomarkers Consortium has learned so far, and how their latest phase aims to deliver biomarkers that can make disease-modifying OA drug trials smaller, faster, and more likely to succeed. Dr. Virginia Byers Kraus is a Professor of Medicine, Pathology, and Orthopaedic Surgery at Duke University School of Medicine. A rheumatologist and translational scientist, her research focuses on osteoarthritis and biomarker development as part of the international FNIH Biomarkers Consortium. Peter G. Mesenbrink, Ph.D., is Executive Director of Biostatistics at Novartis and industry co-chair of the FNIH Biomarkers Consortium. With expertise in adaptive trial design, surrogate endpoint development, and data sharing policy, he is a frequent collaborator across industry, regulatory, and academic communities. Dr. Jamie Collins is a biostatistician at Brigham and Women's Hospital and Associate Professor of Orthopaedic Surgery at Harvard Medical School. As lead statistician for the FNIH OA Biomarkers Consortium, her research focuses on strengthening osteoarthritis clinical trials through innovative trial design and prognostic enrichment. RESOURCES FNIH: Treatment Response Biomarkers for Disease Modifying Osteoarthritis Drugs (DMOADs) CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

What does it actually mean to have 'early-stage' osteoarthritis, and does catching it sooner really make a difference? On this week's episode of Joint Action, learn more about early-stage knee osteoarthritis, how it's defined, and why the EsSKOA initiative is changing the way we identify and understand the condition in its earliest phases. Dr. Armaghan Mahmoudian is an Assistant Professor of Movement Sciences and Health at the University of West Florida, where she teaches anatomy and physiology, biomechanics, and research methods, and co-directs the biomechanics and motor learning laboratory. As a clinician-scientist, her research focuses on understanding disease mechanisms and their impact on function and quality of life, with a particular interest in personalised medicine and disease prevention in an ageing population. RESOURCES EsSKOA InitiativeJournal article Reframing early-stage symptomatic knee osteoarthritis (EsSKOA): A strategic lens for trial design CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

On this week's episode of Joint Action, learn more about how knee braces work, who they help and how they can improve pain and function for people with knee osteoarthritis. Melanie Holden is a Chartered Physiotherapist and the Professor of Musculoskeletal Rehabilitation at the School of Medicine at Keele University. Her current research focuses on how to best manage musculoskeletal pain through rehabilitation using non-drug, non-surgical treatments. Her mission is to create high-quality, innovative research that improves patient care. She is an expert in a wide range of research methods, and she involves patients and the public at every stage of her research, to ensure that it reflects real-world needs and experiences. RESOURCES Journal article Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial CONNECT WITH US Naia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: [email protected]: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.